The EMA perspective on drug approval process in the era of precision medicine

Описание к видео The EMA perspective on drug approval process in the era of precision medicine

Jorge Camarero presents at ecancer's Milan Summit on Precision Medicine 2018 about regloratory challenges in the era or personalised medicine and the European Medicines Agency perspective on the drug approval process.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine

Комментарии

Информация по комментариям в разработке